ARCHIVES

Postdoc Fabricated Results In Published Study, ORI Says.

This article is from The Cancer Letter archive.

Vol. 26 No. 39 | October 27, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Seeks Better Ways to Make Available Fresh Tissue; Iverson Heads Cancer Control Science

October 5, 1984

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

Studies Are Demonstrating Effectiveness Of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 12, 1974